Serum metabolomics based risk assessment of disease recurrence in elderly patients with early breast cancer (eBC)
ANNALS OF ONCOLOGY(2022)
Abstract
Metabolomics studies metabolites in biological samples. Cancer can impair metabolism, so the pattern of altered metabolites could reproduce a “cancer signature”. This analysis aimed at identifying a “metabolic signature” that could differentiate elderly eBC patients (pts) from elderly advanced breast cancer (aBC) pts, as well as at investigating its prognostic role in terms of disease recurrence (DR).
MoreTranslated text
Key words
148p serum metabolomics,early breast cancer,breast cancer
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined